Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
11/2006
11/02/2006EP1003721B1 Benzylidene-1,3-dihydro-indol-2-one derivatives as receptor tyrosine kinase inhibitors, particularly of raf kinases
11/02/2006EP0885883B1 Fused heterocyclic compounds and pharmaceutical applications thereof
11/02/2006EP0821683B1 Benzimidazole compounds and their use as modulators of the gaba a receptor complex
11/02/2006DE102005020002A1 New hexyloxycarbonylamino-imino-methyl-phenylamino-methyl-benzimidazo le-pyridine-propionic acid-ethyl ester salts such as hydrochloride useful for the prophylaxis of vein thrombosis and stroke
11/02/2006CA2607473A1 Herbicidally active phenylsulphonyl-urea
11/02/2006CA2606268A1 Sulfonylamino(thio)carbonyl compounds in the form of herbicides or plant growth regulators
11/02/2006CA2606239A1 Preventive or remedy for bowel disease
11/02/2006CA2606090A1 Physiologically acceptable salts of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazole-5-carbonyl)-pyridin-2-yl-amino] propionic acid ethyl ester
11/02/2006CA2605587A1 Chromane and chromene derivatives and uses thereof
11/02/2006CA2605383A1 Phthalazinone derivative and pharmaceutical comprising the same
11/02/2006CA2604603A1 Novel cyclic amines
11/02/2006CA2604531A1 Vla-4 antagonists
11/02/2006CA2599419A1 Dipeptidyl peptidase-iv inhibitors
11/01/2006CN1856490A Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators
11/01/2006CN1856487A Piperidyl-quinazoline derivatives as tyrosine kinase inhibitors
11/01/2006CN1856486A Substituted lactams and their use as anti-cancer agents
11/01/2006CN1856485A Benzimidazolone and quinazolinone derivatives as agonists on human ORL1 receptors
11/01/2006CN1856477A 异喹啉钾通道抑制剂 Isoquinoline potassium channel inhibitors
11/01/2006CN1856475A 异喹啉钾通道抑制剂 Isoquinoline potassium channel inhibitors
11/01/2006CN1856474A Isoquinolinone potassium channel inhibitors
11/01/2006CN1856473A Isoquinolinone potassium channel inhibitors
11/01/2006CN1856472A Isoquinolinone potassium channel inhibitors
11/01/2006CN1856467A 2-pyridone derivatives as netrophil elastase inhibitors and their use.
11/01/2006CN1856310A 喹唑啉钾通道抑制剂 Quinazoline potassium channel inhibitors
11/01/2006CN1856308A Excitatory amino acid receptor antagonists
11/01/2006CN1856305A Pyridine derivatives and use thereof as urotensin II antagonists
11/01/2006CN1856249A Pyridyl pyrimidines for use as pesticides
11/01/2006CN1854134A Piperazine derivatives and their use as serotonin reuptake inhibitors or as neurokinin antagonists
11/01/2006CN1854128A Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
11/01/2006CN1853630A Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
11/01/2006CN1282644C Indane or indoline derivative
10/2006
10/31/2006US7129359 for treating infection by enterovirus of the Picornaviridae family ; exemplified by: 1-[2-(4'-Chloro-biphenyl-4-yloxymethyl)-benzyl]-3-pyridin-4-yl-imidazolidin-2-one
10/31/2006US7129358 Oxidizing the corresponding sulfide without sulfone production to product purer omerprazole, lansoprazole, pantoprazole, rabeprazole, etc.
10/31/2006US7129357 Cyclization; solvent extraction; hydrolysis; phosphodiesterase (PDE IV) inhibitors
10/31/2006US7129356 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives
10/31/2006US7129354 1-(3-(2-pyridinyloxyethoxy)-2-pyrazinyl)-2-methylpiperazine acid salt derivatives, their preparation and use as serotonin receptor modulators
10/31/2006US7129260 Isoindolinone kinase inhibitors
10/31/2006US7129253 Compounds
10/31/2006US7129252 Six membered amino-amide derivatives an angiogenisis inhibitors
10/31/2006US7129250 Neuroprotective and anti-proliferative compounds
10/31/2006US7129247 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
10/31/2006US7129245 Anticoagulants which act selectively on factor Xa; fast acting; oral; do not interfere with lysis of blood clots
10/31/2006US7129242 Such as 4-((4-chlorophenyl)pyrimidin-2-yl)amino)benzamide; for treatment of inflammation/autoimmune conditions
10/31/2006US7129241 Pyridazine derivatives
10/31/2006US7129236 For therapy of immune related responses, tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis
10/31/2006US7129235 Amides useful for treating pain
10/31/2006US7129234 Selective serotonin re-uptake inhibitors
10/31/2006US7129233 Competitive and selective inhibitors of trypsin-like serine proteases involved in hemostasis; anticoagulants; e.g., 1-((1-haloalkoxy)phenyl)-),2-(hydroxy),ethyl)carbonyl-),2-((4-amidinopyrid-1-yl)methaminocarbonyl)pyrrole
10/31/2006US7129228 Heterocyclic analgesic compounds and methods of use thereof
10/31/2006US7129225 Administering an effective amount of a protein tyrosine kinase inhibitor (containing first and second module) to the patient to protect against or to treat hearing loss
10/31/2006US7129214 Therapy for drug resistant bacteria
10/31/2006CA2355886C Substituted oximes and hydrazones as neurokinin antagonists
10/31/2006CA2276455C Phthalazinones
10/31/2006CA2246126C New piperazine compounds
10/31/2006CA2230672C Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
10/31/2006CA2191759C Formylaminophenylsulfonylureas, preparation processes and use as herbicides and plant growth regulators
10/31/2006CA2186508C Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors
10/26/2006WO2006113864A2 Oxindole compounds and their uses as therapeutic agents
10/26/2006WO2006113769A1 Vanilloid receptor ligands and their use in treatments
10/26/2006WO2006113704A2 Subtituted heteroaryl cb1 antagonists
10/26/2006WO2006113458A1 Heterocyclic inhibitors of protein arginine methyl transferases
10/26/2006WO2006113261A2 Inhibitors of 11-beta hydroxysteroid dehydrogenase type i
10/26/2006WO2006113199A1 Vla-4 antagonists
10/26/2006WO2006112666A1 Pyridine derivatives, methods of their preparations, and pharmaceutical compositions containing the same
10/26/2006WO2006112479A1 Nitrogen-containing heterocyclic compound
10/26/2006WO2006112313A1 Protective agent for retinal neuronal cell comprising indazole derivative as active ingredient
10/26/2006WO2006111560A2 2,3 substituted pyrazine sulfonamides as inhibitors of crth2
10/26/2006WO2006111516A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
10/26/2006WO2006111371A1 Pharmaceutically active diazepanes
10/26/2006WO2006111341A1 Cyano anthranilamide insecticides
10/26/2006WO2006094237A3 Acridine and quinoline dervatives as sirtuin modulators
10/26/2006WO2006093666A3 Isoqunoline compounds and methods of use thereof
10/26/2006WO2006083271A3 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
10/26/2006WO2006078621B1 2-phenoxy-n- (1, 3 , 4-thiadizol-2-yl) pyridin-3-amine derivatives and related compounds as p2y1 receptor inhibitors for the treatment of thromboembolic disorders
10/26/2006WO2006074057A3 Pyrimidine derivatives as kinase modulators and method of use
10/26/2006WO2006010641A3 Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
10/26/2006WO2006006184A3 A process for the manufacturing of loratadine and its intermediates
10/26/2006WO2005105778A3 4-amino-5-cyanopyrimidine derivatives
10/26/2006WO2005095384A8 Pyrazine derivatives and pharmaceutical use thereof as adenosine antagonists
10/26/2006WO2005090311A8 Novel heterocyclyl-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
10/26/2006WO2005087745A8 Novel amido-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
10/26/2006US20060241304 Reaction of a 2-carboxypyrrole or 3-carboxy-2H-pyrazole with a sulfonyl chloride and further condensation with an isatoic anhydride in the presence of a tertiary amine to form the 2-(pyrrol-2-yl or pyrazol-3-yl)benzo[1,3]oxazin-4-one; intermediates for crop protection agents and pharmaceuticals
10/26/2006US20060241302 Morpholine derivatives
10/26/2006US20060241259 for photopolymerization; photography, relief imaging; color filters
10/26/2006US20060241155 TNF-alpha production inhibitors
10/26/2006US20060241153 N-(5-bromo-2-pyridinyl)-(2-4-[(2-aminosulfonyl)phenyl]phenylcarbonylamino)phenylcarboxamide; potent and highly selective inhibitors; coagulation disorders; antithrombotic agents; diagnostic reagents; good bioavailability and/or solubility
10/26/2006US20060241149 Chemical compounds
10/26/2006US20060241148 Fluorinated pyridine N-oxide thrombin modulators and process for N-oxidation of nitrogen containing heteroaryls
10/26/2006US20060241146 2-cyano-1-[t-4-(4-acetyl-1-piperazinyl)-1-methyl-r-1-cyclohexylamino]acetylpyrrolidine; dipeptidylpeptidase IV (DPPIV) inhibitor; antidiabetic, insulin resistance, hyperglycemia, obesity; antiproliferative agent for T-cell, HIV, AIDS; arthritis, osteoporosis
10/26/2006US20060241137 Triazole compounds and the therapeutic use thereof
10/26/2006US20060241127 N-[2-Amino-6-(4-pyridinyl)-4-pyrimidinyl]-N-[2-fluoro-4-(1H-pyrrolo[2,3-b]-pyridin-4-yloxy)phenyl]amine, used for the treatment and/or prophylaxis of cardiovascular diseases and erectile dysfunction
10/26/2006US20060241126 Phospholipase inhibitors perticularly phospholipase A2 enzyme Lipoprotein Associated Phospholipase A2; N-(1-Methylpiperidin-4-yl)-(2-(2-(2,3-difluorophenyl)ethyl)-4-oxo-4H-pyrido[2,3-d]pyrimidin-1-yl)-N-(4-(4-trifluoromethylphenyl)phenyl)methylacetamide; amidation
10/26/2006US20060241123 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
10/26/2006US20060241117 Therapeutic agents useful for treating pain
10/26/2006US20060241115 2,3-Dihydro-4H-1,4-benzoxazine derivatives containing an optionally fused pyridine or pyrimidine ring; 7-((6,7-bis(methyloxy)-4-quinolinyl)oxy)-N-phenyl-2,3-dihydro-4H-1,4-benzoxazine-4-carboxamide; kinase inhibitors; inflammation, angiogenesis and cancer
10/26/2006US20060241114 Derivatives of azasugars as anticancer agents
10/26/2006US20060241113 Polyarylcarboxamides useful as lipid lowering agents
10/26/2006US20060241112 Kinase inhibitors
10/26/2006US20060241110 2-(Imidazol-1-ylalkyl)-3H-quinazolin-4-one derivatives; mitotic kinesin KSP inhibitors; anticarcinogenic, antiinflammatory, and antiproliferative agents
10/26/2006US20060241105 To control arthropods (including insects and arachnids) and helminths (including nematodes) also valuable to protect timber from sawflies, beetles or termites or use in veterinary medicine; 1-(2,6-Dichloro-4-trifluoromethylphenyl)-3-(N-benzyloxy-2-amidino)-5-methylamino-4-trifluoromethylsulfonylpyrazole